| JYHB1800901 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2018-08-01 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-10-10 | view |
| JXHL2300320 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-12-22 | | | | | view |
| CYHS2101144 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(4) | Generic Drug | 2021-05-12 | | Wanbang Biopharmaceuticals | | | view |
| JYHB2000759 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-06-18 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-08-18 | view |
| JXHS1700006 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2017-02-03 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2017-03-24 | view |
| JXHL2400257 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2024-10-25 | | | | | view |
| JXHL2101260 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-11-26 | | | | | view |
| JXHL2000305 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-11-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-11-18 | view |
| JYHF1800014 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2018-02-07 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-03-06 | view |
| JXHS2300086 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-09-21 | | | | | view |
| CYHS2101145 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(4) | Generic Drug | 2021-05-12 | | Wanbang Biopharmaceuticals | | | view |
| JXHL1900320 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-11-22 | | AstraZeneca AB | In Review | 2019-11-21 | view |
| JXHS2400041 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2024-06-21 | | | | | view |
| JXHB2200039 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-03-24 | | AstraZeneca AB | | | view |
| JXHS2000150 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-04-13 | view |
| JYHB1701519 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2017-12-01 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2017-12-20 | view |
| JYHB2300131 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2023-02-21 | | AstraZeneca AB | | | view |
| JXHL2100067 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-03-03 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2021-03-02 | view |
| JYHB2000290 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-04-01 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-05-25 | view |
| JYHB2400369 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2024-07-17 | | AstraZeneca AB | | | view |
